Tedizolid

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.

INDICATIONS

FDA

  • Treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organisms.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: January 11, 2023